| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.89▼ | 6.12▼ | 6.05▼ | 6.91▼ | 5.57▲ |
| MA10 | 6.05▼ | 6.06▼ | 6.12▼ | 6.75▼ | 3.34▲ |
| MA20 | 6.11▼ | 6.17▼ | 6.47▼ | 5.89▼ | 2.47▲ |
| MA50 | 5.90▼ | 6.71▼ | 6.95▼ | 3.09▲ | 2.32▲ |
| MA100 | 6.48▼ | 6.86▼ | 6.70▼ | 2.36▲ | 2.84▲ |
| MA200 | 6.92▼ | 6.39▼ | 4.37▲ | 2.34▲ | 2.48▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.053▼ | 0.030▲ | -0.052▼ | -0.139▼ | 0.631▲ |
| RSI | 36.838▼ | 39.009▼ | 39.600▼ | 54.596▲ | 67.435▲ |
| STOCH | 4.902▼ | 70.002 | 50.680 | 48.224 | 62.683 |
| WILL %R | -86.087▼ | -60.690 | -62.376 | -78.492▼ | -40.972 |
| CCI | -130.143▼ | -30.260 | -77.048 | -118.596▼ | 115.192▲ |
|
Thursday, March 26, 2026 06:33 AM
Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today provided an update on ...
|
|
Tuesday, February 24, 2026 06:15 AM
Results in a population of 278 patients affirm statistically significant mortality reductions Benefits observed across severity groups and in subjects with serious comorbidities Company files ...
|
|
Thursday, February 12, 2026 04:00 PM
TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/03/26 | 5.61 | 6.315 | 5.25 | 5.82 | 767,711 |
| 25/03/26 | 6.76 | 6.95 | 6.12 | 6.57 | 524,500 |
| 24/03/26 | 7.56 | 7.66 | 6.78 | 7.02 | 492,053 |
| 23/03/26 | 7.70 | 8.10 | 6.729 | 7.78 | 1,046,716 |
| 20/03/26 | 7.12 | 9.36 | 6.66 | 7.35 | 2,464,311 |
| 19/03/26 | 7.48 | 7.48 | 6.745 | 7.23 | 550,539 |
| 18/03/26 | 7.18 | 7.69 | 6.70 | 7.69 | 1,565,153 |
| 17/03/26 | 5.27 | 8.13 | 5.26 | 7.00 | 9,040,622 |
| 16/03/26 | 5.61 | 5.65 | 4.85 | 5.12 | 797,562 |
| 13/03/26 | 6.37 | 6.71 | 5.8511 | 5.96 | 620,304 |
|
|
||||
|
|
||||
|
|